For Research Purposes Only

anti-aging

MOTS-c for Age-Related Decline

Preclinical with strong mechanistic data

How It Works

Mitochondrial peptide that activates AMPK and improves glucose uptake.

Research Evidence

Strong preclinical data showing "exercise mimetic" effects. Limited human studies.

Dosing Protocol

5-10mg 2-3x weekly subcutaneously.

Important Considerations

  • !Very limited human data
  • !Expensive
  • !Early research
  • !Consult healthcare provider before use
  • !Quality sourcing is critical

Frequently Asked Questions

Does MOTS-c work for age-related decline?

Strong preclinical data showing "exercise mimetic" effects. Limited human studies. Research level: Preclinical with strong mechanistic data.

How does MOTS-c help with age-related decline?

Mitochondrial peptide that activates AMPK and improves glucose uptake.

What is the MOTS-c dosage for age-related decline?

5-10mg 2-3x weekly subcutaneously.

Is MOTS-c safe for age-related decline?

Key considerations: Very limited human data. Expensive. Early research. Consult healthcare provider before use. Quality sourcing is critical. Always consult a healthcare provider.

How long until MOTS-c works for age-related decline?

Results vary by individual and condition severity. Most users report initial effects within 2-4 weeks, with full benefits developing over 8-12 weeks of consistent use.

Learn More

Disclaimer: This information is for educational and research purposes only. MOTS-c is not FDA approved for this use. Consult qualified healthcare professionals.